Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tandem Diabetes Care (NQ: TNDM )

21.19 +0.95 (+4.69%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,415,933
Open 19.93
Bid (Size) 18.00 (2)
Ask (Size) 21.18 (1)
Prev. Close 20.24
Today's Range 18.45 - 21.21
52wk Range 13.82 - 47.17
Shares Outstanding 63,029,361
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Increase Prevalence of Diabetic Patients Driving Market Growth Projected to Reach $55 Billion by 2029
EQNX::TICKER_START (OTCPK:CNER),(NASDAQ:PODD),(NASDAQ:TNDM),(NYSE:LLY),(NYSE:ABT) EQNX::TICKER_END 
Via FinancialNewsMedia
Exposures COVID-19
NASDAQ:TNDM Investor Notice: Deadline on November 7, 2023 in Lawsuit Against Tandem Diabetes Care, Inc. Coming Up
San Diego, CA -- (SBWIRE) -- 11/07/2023 -- The Shareholders Foundation announced that a deadline is coming up on November 7, 2023 in the lawsuit filed for certain investors of Tandem Diabetes Care,... 
Via SBWire
Topics Lawsuit
Exposures Financial Legal

Performance

YTD
-52.45%
-52.45%
1 Month
+34.54%
+34.54%
3 Month
-22.24%
-22.24%
6 Month
-12.62%
-12.62%
1 Year
-50.07%
-50.07%

More News

Read More
Tandem Diabetes Care Announces Upcoming Conference Presentations
From Tandem Diabetes Care, Inc.
Via Business Wire
TNDM DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM
From The Rosen Law Firm PA
Via GlobeNewswire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)
From The Law Offices of Frank R. Cruz
Via Business Wire
TNDM FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
TNDM IMPORTANT DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
TANDEM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
Via Benzinga
Topics Economy
Exposures Interest Rates
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer
From Tandem Diabetes Care, Inc.
Via Business Wire
Tandem Diabetes Care Announces Third Quarter 2023 Financial Results
From Tandem Diabetes Care, Inc.
Via Business Wire
DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – TNDM
From The Rosen Law Firm PA
Via GlobeNewswire
TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Earnings Scheduled For November 1, 2023
Via Benzinga
TANDEM ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action - TNDM
Via NewMediaWire
Topics Economy Lawsuit
Exposures Financial Interest Rates Legal
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Via Investor's Business Daily
Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond
Via The Motley Fool
TNDM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Global Diabetes Care Market Size Expected To Reach $41.71 Billion By 2027
Via FinancialNewsMedia
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.